Guam Technology Journal
SEE OTHER BRANDS

Get your science and technology news from Guam

Guam Technology Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guam Technology Journal.

Press releases published on July 21, 2025

CARBIOS steigt in den Markt für r-PET-Filamente für Reifenverstärkungsgewebe ein

CARBIOS steigt in den Markt für r-PET-Filamente für Reifenverstärkungsgewebe ein

CARBIOS hat eine mehrjährige kommerzielle Vereinbarung mit Indorama Ventures, dem weltweit führenden Hersteller von Polyester, unterzeichnet. CARBIOS wird in diesem Rahmen recycelte Monomere bereitstellen, die von Indorama Ventures zu Filamenten für die …

CARBIOS enters the r-PET market for tire textile filaments

CARBIOS enters the r-PET market for tire textile filaments

CARBIOS has signed a multi-year commercial agreement with Indorama Ventures, the world leader in polyester production. CARBIOS will supply recycled monomers that will be transformed into filaments by Indorama Ventures, intended for use in tire …

CARBIOS entre dans le marché du r-PET destiné aux filaments textiles pour pneumatiques

CARBIOS entre dans le marché du r-PET destiné aux filaments textiles pour pneumatiques

CARBIOS a signé un engagement commercial pluriannuel avec Indorama Ventures, leader mondial du polyester. CARBIOS fournira les monomères recyclés qui seront transformés en filaments par Indorama Ventures, et destinés au renfort de pneumatiques pour …

StablR Secures Strategic Investment from Kraken as Stablecoin Adoption Surges

StablR Secures Strategic Investment from Kraken as Stablecoin Adoption Surges

AMSTERDAM, July 21, 2025 (GLOBE NEWSWIRE) -- StablR, a leading European stablecoin issuer, proudly announces a strategic investment from Kraken, a technology platform built on crypto that unlocks access and reduces inefficiencies to drive financial freedom …

Cologix Closes $525 Million USD Asset-Backed Securitization to Support AI Infrastructure, Interconnection and Growth

Cologix Closes $525 Million USD Asset-Backed Securitization to Support AI Infrastructure, Interconnection and Growth

DENVER, July 21, 2025 (GLOBE NEWSWIRE) -- Cologix, a leading network-neutral interconnection and hyperscale edge data center company in North America, today announced that it has closed a $525 million USD asset-backed securitization (ABS) to support the …

Cologix conclut une titrisation adossée à des actifs de 525 millions de dollars américains pour soutenir l’infrastructure, l’interconnexion et la croissance de l’IA

Cologix conclut une titrisation adossée à des actifs de 525 millions de dollars américains pour soutenir l’infrastructure, l’interconnexion et la croissance de l’IA

DENVER, 21 juill. 2025 (GLOBE NEWSWIRE) -- Cologix, le chef de file nord-américain d’interconnexions neutres et des centres de données hyperscale edge, a annoncé aujourd’hui qu’elle a conclu une titrisation, adossée à des actifs sécurisés (ABS), de 525 …

Longeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease

Longeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease

Longeveron has licensed issued US Patent 12,168,028 B2, entitled “Methods for obtaining cardiomyogenic precursor cells” from the University of Miami New patent protects a method to derive GHRH-Receptor+ cardiomyogenic cells from pluripotent stem cells ( …

ONAR Appoints Former MDC Partners Chairman & CEO Scott Kauffman to Lead Board, Signaling Aggressive Growth Strategy

ONAR Appoints Former MDC Partners Chairman & CEO Scott Kauffman to Lead Board, Signaling Aggressive Growth Strategy

Miami, FL, July 21, 2025 (GLOBE NEWSWIRE) -- ONAR Holding Corporation (OTCQB: ONAR), a fast-growing marketing technology company and global network of performance-driven agencies, today announced the appointment of Scott Kauffman, former Chairman and CEO …

CentralReach Adds Workforce Management System Viventium to Preferred Partnership Network

CentralReach Adds Workforce Management System Viventium to Preferred Partnership Network

Fort Lauderdale, FL, July 21, 2025 (GLOBE NEWSWIRE) -- CentralReach, a leading provider of Autism and IDD Care software for ABA, multidisciplinary, and special education, today announced a new preferred partnership with Viventium, an industry-leading …

Edge Conversion Launches Custom AI Systems to Supercharge Sales and Scale Growth for Small Businesses

Edge Conversion Launches Custom AI Systems to Supercharge Sales and Scale Growth for Small Businesses

Los Angeles, California, July 21, 2025 (GLOBE NEWSWIRE) -- Edge Conversion, an emerging AI automation agency based in Los Angeles, has unveiled a suite of tailored AI systems that simplify operations and supercharge growth for service-based and online …

FloQast Named to CNBC’s 2025 List of World’s Top Fintech Companies in Enterprise Category

FloQast Named to CNBC’s 2025 List of World’s Top Fintech Companies in Enterprise Category

LOS ANGELES, July 21, 2025 (GLOBE NEWSWIRE) -- FloQast, an Accounting Transformation Platform created by accountants for accountants, today announced it has been named to CNBC’s 2025 list of the World’s Top Fintech Companies, securing a spot in the …

Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq

Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq

SAN DIEGO, July 21, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today …

Senti Bio’s Chief Medical Officer, Kanya Rajangam, M.D., Ph.D. to Give Feature Presentation at the BioScience Forum

Senti Bio’s Chief Medical Officer, Kanya Rajangam, M.D., Ph.D. to Give Feature Presentation at the BioScience Forum

SOUTH SAN FRANCISCO, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …

Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors

Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors

- New board members bring decades of experience in company building, corporate strategy, commercialization, and business development CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company …

Bit Origin Acquires Over 40 Million Dogecoin (DOGE) to Advance Treasury Strategy

Bit Origin Acquires Over 40 Million Dogecoin (DOGE) to Advance Treasury Strategy

SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Bit Origin Ltd (NASDAQ: BTOG) ("Bit Origin" or the "Company"), today announced the initial purchase of approximately 40.5 million DOGE. This represents the first strategic acquisition under the Company's digital …

Urteste S.A. Completes Development of Panuri Test – Company Plans to Launch Clinical Study in Q3 2025

Urteste S.A. Completes Development of Panuri Test – Company Plans to Launch Clinical Study in Q3 2025

Urteste S.A. Completes Development of Panuri Test – Company Plans to Launch Clinical Study in Q3 2025 Gdańsk, Poland - July 21, 2025 - Urteste S.A. (Warsaw Stock Exchange: URT), a company specializing in the development of innovative technology for cancer …

Arbe to Announce Second Quarter 2025 Financial Results  and to Hold a Conference Call on August 7, 2025

Arbe to Announce Second Quarter 2025 Financial Results and to Hold a Conference Call on August 7, 2025

Tel Aviv, Israel, July 21, 2025 — Arbe Robotics Ltd. (Nasdaq, TASE: ARBE), a global leader in perception radar solutions, today announced that it will hold its second quarter 2025 conference call on Thursday, August 7, 2025 at 8:30 a.m. Eastern Time. The …

UroGen Announces Five-Year Long-Term Extension Study of the OPTIMA II Trial Demonstrates Long-Term Durability of Response to ZUSDURI™ in Patients with Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

UroGen Announces Five-Year Long-Term Extension Study of the OPTIMA II Trial Demonstrates Long-Term Durability of Response to ZUSDURI™ in Patients with Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Findings published in the journal of Clinical Genitourinary Cancer show patients remained event-free for a median of two years after achieving complete response with ZUSDURI (mitomycin) intravesical solution. Among the 17 patients who achieved complete …

NKGen Receives FDA Expanded Access Protocol Authorization for Landmark Treatment of Several Neurodegenerative Diseases

NKGen Receives FDA Expanded Access Protocol Authorization for Landmark Treatment of Several Neurodegenerative Diseases

Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit without any drug-related adverse events in two Phase I clinical trials in Alzheimer’s Disease. Company receives expanded access …

Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025

Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025

WALTHAM, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service